), if the acidity in the two media differs (6). We attribute the good correlation between serum and the ultraflltrate of saliva to the fact that the osmotic device moderately stimulates salivary secretion.
The pH of resting saliva can be as low as 5.9 (7) , but an increased flow rate stabilizes the acidity between pH 7.4 and 7.6 (8), at which values the distribution ratio between saliva and plasma reaches a plateau (Figure 1) .
Changes in salivary flow rate can markedly affect the secretion of sodium and other electrolytes (9). Therefore, concern has occasionally been expressed that drug concentrations might also be affected by the salivary secretion rate. Although each drug needs to be investigated separately, this concern is not supported by the large number of studies that show a good correlation between saliva and serum for phenytoin, carbamazepine, and phenobarbital (10). Likewise, theoretical considerations (ii) and experimental results show independence of concentrations from flow rate for many steroids (12-14).
The evaluation of the degree of plasma protein binding is of diagnosticvalue for many drugs and secretedmolecules. The three commonly used methods to separate "free" from "bound" components in plasma are equilibrium dialysis, ultrafiltration, and ultracentrifugation (15-18). All of these procedures are time consuming and labor intensive to perform in the laboratory. Saliva, being a natural ultrafiltrate of plasma, is therefore a superior medium for diagnostic evaluation of the free circulating componentof many molecules. The described method of collecting an ultrafiltrate of saliva in situ overcomes many of the commonly encountered difficulties in collecting and processing saliva.
pH of Saliva albumin (1,2) .
We compared FF concentrations as determined by this kit and by a new one-step radioimmunoassay, Ria-gnost from Behring (Marburg, F.R.G.) , in serum from euthyroid hospitalized patients: hemodialized (IRC) patients (n = 19) and patients with severe acute or chronic nonthyroidal illness (e.g., cardiac, hepatic, pulmonary, bacterial infection, end-stage malignancy) (Nil): without hypoalbuminemia (NTIa) (n = 26), and with hypoalbuminemia (albumin <30 g/L) (NTIb) (n = 33). The control group consisted of 34 hospitalized patients without severe systemic illness.
Compared with the controls, Fr3 concentrations were markedly decreased in the IRC and NTIb groups when measuredby the Amerlex-M kit and moderately decreased in the NTIb group when measured by the Ria-gnost kit ( 
Ria-gnost
results agreed more closely with ED results than with those obtained with the Amerlex-M kit. The decrease in Fr3 concentrations measured by the Ria-gnost kit in the NTIb group could be related to the severity of the illnesses of these patients (2); it was not an artifact attributable to the interaction of the tracer with serum proteins. In fact, in this group we did not obtain a statistically different mean FF3 (3.27 pmol/L) when the Ria-gnost kit was used according to a two-step protocol to avoid contact between tracer and serum proteins.
These findings suggest that in the hospitalized patients with severe illnesses (IRC and hypoalbuminemia) the Riagnost Fr3 assay, giving results less decreased than those by the Amerlex-M kit, should be preferred. The discrepancies between results of the two assays may be attributable to the nature of the tracers used in the kits. Behring's kit involves the use of a modified tracer (aT3 derivative having a structure similar to that of the immunogen) vs a analog in the Amerlex-M kit.
